| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/05/2009 | US7528110 Anti-allergic complex molecules |
| 05/05/2009 | US7527810 Oral immunology using plant product containing hepatitis surface antigen |
| 05/05/2009 | CA2606624A1 Methods and compositions for treating and preventing malaria (2) |
| 05/05/2009 | CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 05/05/2009 | CA2253790C Methods of enhancing anti-tumour immunity in a mammal |
| 05/05/2009 | CA2146647C Treatment of autoimmune and inflammatory disorders |
| 04/30/2009 | WO2009054747A1 Anti-metastatic agent |
| 04/30/2009 | WO2009054556A1 Method for preparation of therapeutic b cells against autoimmune diseases which are induced by autoimmune cytotoxicity |
| 04/30/2009 | WO2009054471A1 Immune response inducer |
| 04/30/2009 | WO2009054454A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
| 04/30/2009 | WO2009054321A1 IMMUNOGLOBULIN IgA CLASS SWITCHING AGENT |
| 04/30/2009 | WO2009054001A1 A pharmaceutical composition and a process thereof |
| 04/30/2009 | WO2009053799A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| 04/30/2009 | WO2009053718A2 Immuno-modulatory composition |
| 04/30/2009 | WO2009053683A2 Treatment of inflammatory diseases |
| 04/30/2009 | WO2009053604A2 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 04/30/2009 | WO2009053601A2 Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant |
| 04/30/2009 | WO2009053514A1 Method for the diagnosis and treatment of diseases which develop with alteration of kinase p38, elements necessary therefor and applications thereof |
| 04/30/2009 | WO2009053512A1 Porcine torovirus proteins n, m and he, method for production thereof and uses thereof in diagnosis and treatment of porcine torovirus |
| 04/30/2009 | WO2009052708A1 1-(3-amino-propyl)-piperidin-4-yl-amides, pharmaceutical compositions, processes for their preparation and uses |
| 04/30/2009 | WO2009052629A1 Compositions and methods for enhancing immune response |
| 04/30/2009 | WO2009052561A1 Compositions and methods for manipulating an immune response |
| 04/30/2009 | WO2009052555A1 Immunogenic protein pas n 1 from bahia grass pollen |
| 04/30/2009 | WO2009033733A3 Use of apeptide as a therapeutic agent |
| 04/30/2009 | WO2009027077A8 5-arylalkylidene-2-arylalkyl-thiazol-4-one derivatives as inhibitors of 5-lipoxygenase and uses thereof |
| 04/30/2009 | WO2008141119A3 Modulators of cftr |
| 04/30/2009 | WO2008140421A3 Heterocycloalkyl substituted pyrimidine derivatives |
| 04/30/2009 | WO2008140420A3 Pyrimidine derivatives |
| 04/30/2009 | WO2008140419A3 Pyridyl substituted pyrimidine derivatives |
| 04/30/2009 | WO2008138889A3 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 04/30/2009 | WO2008119042A3 Combination of blys inhibition and/or april inhibition and immunnosuppressants for treatment of autoimmune disease |
| 04/30/2009 | WO2005010169A3 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
| 04/30/2009 | US20090111879 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of asthma, inflammatory bowel disease, rheumatoid arthritis and atopic dermatitis |
| 04/30/2009 | US20090111866 Novel Compounds |
| 04/30/2009 | US20090111819 New pyridazin-3(2h)-one derivatives |
| 04/30/2009 | US20090111807 Novel 1,2,3,4-Tetrahydroquinoxaline Derivative Having Glucocorticoid Receptor Binding Activity |
| 04/30/2009 | US20090111806 Azaquinolone based compounds exhibiting prolyl hydroxylase Inhibitory activity, compositions, and uses thereof |
| 04/30/2009 | US20090111803 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/30/2009 | US20090111794 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase |
| 04/30/2009 | US20090111778 2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase |
| 04/30/2009 | US20090111765 Compositions and methods for immunostimulatory rna oligonucleotides |
| 04/30/2009 | US20090110699 Antigen-Adjuvant Compositions and Methods |
| 04/30/2009 | US20090110692 Isolated complexes of endotoxin and modified md-2 |
| 04/30/2009 | US20090110639 Predicting vaccine efficacy |
| 04/30/2009 | DE10128250B4 Neue Glykolipidderivate, Verfahren zu deren Herstellung und diese enthaltende Mittel Glykolipidderivate new, processes for their preparation and compositions comprising them |
| 04/30/2009 | CA2740960A1 Immuno-modulatory composition |
| 04/30/2009 | CA2704098A1 Compositions and methods for enhancing immune response |
| 04/30/2009 | CA2703350A1 Immune response inducer |
| 04/30/2009 | CA2700430A1 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 04/30/2009 | CA2609172A1 Immunotherapy compositions for use with targeted therapy in the treatment of cancer |
| 04/29/2009 | EP2053123A1 Method of proliferating lak cell |
| 04/29/2009 | EP2053061A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 04/29/2009 | EP2053038A1 Aminoalcohol derivative and immunosuppressant containing the same as an active ingredient |
| 04/29/2009 | EP2052742A1 Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combination |
| 04/29/2009 | EP2052713A2 Soluble FcgammaR fusion proteins and methods of use thereof |
| 04/29/2009 | EP2052085A2 Methods for modulating set and uses thereof |
| 04/29/2009 | EP2051997A1 Anti-c5ar antibodies with improved properties |
| 04/29/2009 | EP2051987A2 Use of cd83 in combination therapies |
| 04/29/2009 | EP2051984A1 Crystalline forms of rapamycin analogs |
| 04/29/2009 | EP2051728A2 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
| 04/29/2009 | EP2051718A2 Mesenchymal stem cells and uses therefor |
| 04/29/2009 | EP2051705A2 Use of glucocorticoid receptor antagonists for treatment of infectious conditions |
| 04/29/2009 | EP1485347B1 Hif hydroxylase inhibitors for use in the treatment of anaemia |
| 04/29/2009 | EP1345910B1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | EP1066286B1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 04/29/2009 | CN201227079Y Far infrared cassia seed pillow |
| 04/29/2009 | CN101420966A Use of non-digestable sacharides for giving an infant the best start after birth |
| 04/29/2009 | CN101418270A High density culture method of lactobacillus casei Zhang, method for preparing freeze-dried powder by using the same and obtained freeze-dried powder and uses thereof |
| 04/29/2009 | CN101418032A Method for synthesizing deflazacort |
| 04/29/2009 | CN101417912A Method for preparing becort acetate |
| 04/29/2009 | CN101417129A Gabapentin analogues for fibromyalgia and other related disorders |
| 04/29/2009 | CN101417127A Female capsules capable of invigorating the kidney and moistening the face |
| 04/29/2009 | CN101417120A Methods for inducing sustained immune response |
| 04/29/2009 | CN101417103A Traditional Chinese medicine formulation for treating hyperplasia prostate |
| 04/29/2009 | CN101417008A Biberberine for injection as veterinary herb medicine composite preparation and preparation technique and use thereof |
| 04/29/2009 | CN101416999A Traditional Chinese medicine formulation for treating cerebrovascular disease |
| 04/29/2009 | CN101416996A Plant desensitizer and preparation method thereof |
| 04/29/2009 | CN101416981A Tourmaline active element and preparation method thereof |
| 04/29/2009 | CN101416960A Use of coumarether and composition thereof |
| 04/29/2009 | CN101416953A Tacrolimus soft capsules and preparation method thereof |
| 04/29/2009 | CN100482795C IREN protein, its preparation and use |
| 04/29/2009 | CN100482688C Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482665C Pyrazolo 1,5-a pyrimidine derivatives |
| 04/29/2009 | CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 04/29/2009 | CN100482278C Micro-cluster liquids and methods of making and using them |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/29/2009 | CN100482262C Herbal pharmaceutical compositions for treating immun logical disorders |
| 04/29/2009 | CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers |
| 04/28/2009 | US7524975 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 04/28/2009 | US7524949 Prevention or therapy of cardiovascular complications |
| 04/28/2009 | US7524944 polynucleotide encoding peptide domain of CD40 ligand lacking a matrix metalloproteinase cleavage sites, used as immunology modulators, vaccines and treatments of human diseases, including malignancies and autoimmune diseases |
| 04/28/2009 | US7524930 polypeptides consisting of amino acid sequences or peptide fragments and drug carriers, used for inducing and/or activating human leukocyte antigens (HLA-A2)-restricted tumor-specific cytotoxic T lymphocytes; anticancer vaccines |
| 04/28/2009 | US7524883 Eponemycin and epoxomicin analogs and uses thereof |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524858 Substituted pyrroline kinase inhibitors |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |